AnaptysBio (ANAB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Off Shifts Pipeline To First Tracks Biotherapeutics GSK: 'Strong Buy' On Mo-Rez Oncology Expansion Potential AnaptysBio: Upside Constrained By Undifferentiated Data, Legal Uncertainties AnaptysBio ...

AnaptysBio Inc. ANAB shares are up on Monday as the company celebrates a favorable ruling from the Delaware Chancery Court ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has AnaptysBio, Inc. (ANAB) been one of those stocks this year?

Multiple analysts have issued price targets for $ANAB recently. We have seen 6 analysts offer price targets for $ANAB in the last 6 months, with a median target of ...